CIRCASSIA GROUP PLC

CIR
Delayed Quote. Delayed  - 10/20 11:35:21 am
45.15GBX +3.32%

Turn to zoom
Prev.43.7000
Open44.0500
High45.6650
Low44.0500
Volume480 149
Latest news
09/30
09/16
09/16
09/16
Chart CIRCASSIA GROUP PLC
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance45,945,945,9
Spread/Res.-1,5%-1,5%-1,5%
Spread/Supp.9,5%21%33%
Support41,337,334,0
Financials
Sales 2021 61,4 M 84,9 M 84,9 M
Net income 2021 - - -
Net cash 2021 9,55 M 13,2 M 13,2 M
P/E ratio 2021 -
Yield 2021 -
Capitalization 189 M 261 M 261 M
EV / Sales 2021 2,91x
EV / Sales 2022 2,17x
Nbr of Employees 162
Free-Float 44,2%
Company
Circassia Group Plc, formerly Circassia Pharmaceuticals Plc, is a specialty biopharmaceutical company focused on allergy and respiratory diseases. The Company is primarily focused on offering its commercialized asthma management products directly to specialist physicians in various markets. The...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2022-04-26 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 0,45 
Average target price
Spread / Average Target -